Evidence reviews - October 2022
The following document contains the evidence that was used to develop the 2022 recommendations:
- A: Additional benefit of imaging in the diagnosis of osteoarthritis
- B: Post-diagnostic information on osteoarthritis for people with osteoarthritis, their family and carers
- C: Clinical and cost effectiveness of exercise for the management of osteoarthritis
- D: Clinical and cost effectiveness of manual therapy for the management of osteoarthritis
- E: Clinical and cost effectiveness of manual therapy for the management of osteoarthritis
- F: Clinical and cost effectiveness of acupuncture for people with osteoarthritis
- G: Clinical and cost effectiveness of electrotherapy for the management of osteoarthritis
- H: Clinical and cost effectiveness of devices for the management of osteoarthritis
- I: Clinical and cost effectiveness of oral, topical and transdermal medicines for the management of osteoarthritis
- I: Clinical and cost effectiveness of oral, topical and transdermal medicines for the management of osteoarthritis: appendices A to D
- I: Clinical and cost effectiveness of oral, topical and transdermal medicines for the management of osteoarthritis: appendices E to J
- J: Clinical and cost-effectiveness of intra-articular injections for the management of osteoarthritis
- K: Clinical and cost effectiveness of treatment packages for the management of osteoarthritis
- L: Regular follow-up and review
- M: Clinical and cost effectiveness of imaging during the management of osteoarthritis
- N: Clinical and cost effectiveness of arthroscopic procedures for the management of osteoarthritis
- O: Indicators for referral for possible joint replacement surgery
- P: Outcomes of joint replacement surgery dependent on body mass index
This page was last updated: